A trial looking at lowering the risk of hearing loss after cisplatin chemotherapy in children or young people with hepatoblastoma (SIOPEL 6)

Overview

Cancer types:

Children's cancers

Status:

Results

Phase:

Phase 3

Details

This trial was done to find out if sodium thiosulphate can reduce high frequency hearing loss, which can be a side effect of cisplatin chemotherapy. It was for children and young people up to the age of 18 with hepatoblastoma that had not spread to another part of the body.

The trial was supported by Cancer Research UK.

Recruitment start: 15 December 2007

Recruitment end: 1 December 2014

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr M. Ronghe

Supported by

Cancer Research UK

Cancer Research UK Children's Cancer Trials Team

University of Birmingham

NIHR Clinical Research Network: Cancer

Other information

This is Cancer Research UK trial number CRUK/07/023.

Last reviewed: 2 August 2018

CRUK internal database number: 1107

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.